Acceder Registro /

Elisa GARCÍA VÁZQUEZ

Buscador

Sojo-Dorado J, Lopez-Hernandez I, Hernandez-Torres A, Retamar-Gentil P, Merino de Lucas E, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jimenez V, Docobo-Perez F, Pascual A, Rodriguez-Bano J. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. J Antimicrob Chemother. 2023 Jul 5;78(7):1658-1666. doi: 10.1093/jac/dkad147. PubMed PMID: 37260299; PubMed Central PMCID: PMC10775153.
AÑO: 2023; IF: 5.2
Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo A, Diaz-Pena R; Scourge Cohort Group. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19. HLA. 2023 Dec;102(6):731-739. doi: 10.1111/tan.15160. Epub 2023 Aug 1. PubMed PMID: 37528566.
AÑO: 2023; IF: 8.0
Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enriquez-Gomez A, Munoz P, Plata-Ciezar A, Miro JM, Alarcon A, Martinez-Marcos FJ, Loeches B, Escrihuela-Vidal F, Vinuesa D, Herrero C, Boix-Palop L, Del Mar Arenas M, Vazquez EG, de Las Revillas FA, Pasquau J; EN-DALBACEN study group. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci. Int J Antimicrob Agents. 2023 Sep;62(3):106918. doi: 10.1016/j.ijantimicag.2023.106918. Epub 2023 Jul 11. PubMed PMID: 37442488.
AÑO: 2023; IF: 10.8
Escrihuela-Vidal F, Berbel D, Fernandez-Hidalgo N, Escola-Verge L, Munoz P, Olmedo M, Goenaga MA, Goikoetxea J, Farinas MC, De Alarcon A, Miro JM, Ojeda G, Plata A, Cuervo G, Carratala J; GAMES Investigators. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci. Clin Infect Dis. 2023 Nov 11;77(9):1273-1281. doi: 10.1093/cid/ciad375. PubMed PMID: 37345869.
AÑO: 2023; IF: 11.8
Vicent L, Goenaga MA, Munoz P, Marin-Arriaza M, Valerio M, Farinas MC, Cobo-Belaustegui M, de Alarcon A, Rodriguez-Esteban MA, Miro JM, Goikoetxea-Agirre AJ, de Castro Campos D, Garcia-Vazquez E, Martinez-Selles M; GAMEs investigators. Infective endocarditis in children and adolescents: a different profile with clinical implications. Pediatr Res. 2022 Nov;92(5):1400-1406. doi: 10.1038/s41390-022-01959-3. Epub 2022 Feb 11. PubMed PMID: 35149848.
AÑO: 2022; IF: 3.6

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R